Evolution Wealth Advisors, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Evolution Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$8.62 - $13.9 $1,836 - $2,960	-213 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$11.68 - $20.72 $3,796 - $6,734	-325 Reduced 60.41%	213 $3,000
Q1 2021 Apr 20, 2021	SELL	$20.25 - $39.49 $4,029 - $7,858	-199 Reduced 27.0%	538 $11,000
Q4 2020 Feb 02, 2021	SELL	$21.17 - $32.61 $2,011 - $3,097	-95 Reduced 11.42%	737 $22,000
Q1 2020 Apr 22, 2020	BUY	$13.16 - $22.9 $921 - $1,603	70 Added 9.19%	832 $13,000
Q4 2019 Feb 03, 2020	BUY	$19.53 - $25.5 $13,866 - $18,105	710 Added 1365.38%	762 $17,000
Q3 2019 Nov 12, 2019	SELL	$18.62 - $24.51 $9,514 - $12,524	-511 Reduced 90.76%	52 $1,000
Q2 2019 Jul 12, 2019	BUY	$21.11 - $28.48 $11,884 - $16,034	563 New	563 $12,000

191

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.